1 |
KOMLÓS G, CSURGAY K, HORVÁTH F, et al. Periodontitis as a risk for oral cancer: a case-control study[J]. BMC Oral Health, 2021, 21(1): 640.
|
2 |
SANZ M, MARCO DEL CASTILLO A, JEPSEN S, et al. Periodontitis and cardiovascular diseases: consensus report[J]. J Clin Periodontol, 2020, 47(3): 268-288.
|
3 |
王兴. 第四次全国口腔健康流行病学调查报告[M]. 北京: 人民卫生出版社, 2018.
|
|
WANG X. Report on the Fourth National Epidemiological Survey of Oral Health[M]. Beijing: People's Health Publishing House, 2018.
|
4 |
KAVARTHAPU A, GURUMOORTHY K. Linking chronic periodontitis and oral cancer: a review[J]. Oral Oncol, 2021, 121: 105375.
|
5 |
ALLON I, ABBA M, KAPLAN I, et al. Oral variant of acantholytic squamous cell carcinoma: histochemical and immunohistochemical features[J]. Acta Histochem, 2019, 121(8): 151443.
|
6 |
MORRISON A G, SARKAR S, UMAR S, et al. The contribution of the human oral microbiome to oral disease: a review[J]. Microorganisms, 2023, 11(2): 318.
|
7 |
LAMONT R J, FITZSIMONDS Z R, WANG H Z, et al. Role of Porphyromonas gingivalis in oral and orodigestive squamous cell carcinoma[J]. Periodontol 2000, 2022, 89(1): 154-165.
|
8 |
GENG F X, LIU J C, GUO Y, et al. Persistent exposure to Porphyromonas gingivalis promotes proliferative and invasion capabilities, and tumorigenic properties of human immortalized oral epithelial cells[J]. Front Cell Infect Microbiol, 2017, 7: 57.
|
9 |
KYLMÄ A K, SORSA T, JOUHI L, et al. Prognostic role of Porphyromonas gingivalis gingipain rgp and matrix metalloproteinase 9 in oropharyngeal squamous cell carcinoma[J]. Anticancer Res, 2022, 42(11): 5415-5430.
|
10 |
GUO K, LIU Y K, ZHOU H J, et al. Involvement of protein kinase C β-extracellular signal-regulating kinase 1/2/p38 mitogen-activated protein kinase-heat shock protein 27 activation in hepatocellular carcinoma cell motility and invasion[J]. Cancer Sci, 2008, 99(3): 486-496.
|
11 |
张桓瑜, 江旖婷, 朱晓晨, 等. 牙龈素提取物对小鼠脑神经炎症的影响[J]. 上海交通大学学报(医学版), 2022, 42(5): 570-577.
|
|
ZHANG H Y, JIANG Y T, ZHU X C, et al. Effects of gingipain extracts on brain neuroinflammation in mice[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(5): 570-577.
|
12 |
KOLIARAKIS I, MESSARITAKIS I, NIKOLOUZAKIS T K, et al. Oral bacteria and intestinal dysbiosis in colorectal cancer[J]. Int J Mol Sci, 2019, 20(17): 4146.
|
13 |
MALINOWSKI B, WĘSIERSKA A, ZALEWSKA K, et al. The role of Tannerella forsythia and Porphyromonas gingivalis in pathogenesis of esophageal cancer[J]. Infect Agent Cancer, 2019, 14: 3.
|
14 |
TAN Q, MA X, YANG B, et al. Periodontitis pathogen Porphyromonas gingivalis promotes pancreatic tumorigenesis via neutrophil elastase from tumor-associated neutrophils[J]. Gut Microbes, 2022, 14(1): 2073785.
|
15 |
GAO S G, LI S G, MA Z K, et al. Presence of Porphyromonas gingivalis in esophagus and its association with the clinicopathological characteristics and survival in patients with esophageal cancer[J]. Infect Agent Cancer, 2016, 11: 3.
|
16 |
LIU Y W, YUAN X, CHEN K S, et al. Clinical significance and prognostic value of Porphyromonas gingivalis infection in lung cancer[J]. Transl Oncol, 2021, 14(1): 100972.
|
17 |
CHANG C R, WANG H Y, LIU J C, et al. Porphyromonas gingivalis infection promoted the proliferation of oral squamous cell carcinoma cells through the miR-21/PDCD4/AP-1 negative signaling pathway[J]. ACS Infect Dis, 2019, 5(8): 1336-1347.
|
18 |
WOO B H, KIM D J, CHOI J I, et al. Oral cancer cells sustainedly infected with Porphyromonas gingivalis exhibit resistance to Taxol and have higher metastatic potential[J]. Oncotarget, 2017, 8(29): 46981-46992.
|
19 |
LIU S Y, ZHOU X D, PENG X, et al. Porphyromonas gingivalis promotes immunoevasion of oral cancer by protecting cancer from macrophage attack[J]. J Immunol, 2020, 205(1): 282-289.
|
20 |
INABA H, SUGITA H, KUBONIWA M, et al. Porphyromonas gingivalis promotes invasion of oral squamous cell carcinoma through induction of proMMP9 and its activation[J]. Cell Microbiol, 2014, 16(1): 131-145.
|
21 |
OHSHIMA J, WANG Q, FITZSIMONDS Z R, et al. Streptococcus gordonii programs epithelial cells to resist ZEB2 induction by Porphyromonas gingivalis[J]. Proc Natl Acad Sci USA, 2019, 116(17): 8544-8553.
|
22 |
REN J L, HAN X, LOHNER H, et al. P. gingivalis infection upregulates PD-L1 expression on dendritic cells, suppresses CD8+ T-cell responses, and aggravates oral cancer[J]. Cancer Immunol Res, 2023, 11(3): 290-305.
|
23 |
WHEELOCK M J, JOHNSON K R. Cadherins as modulators of cellular phenotype[J]. Annu Rev Cell Dev Biol, 2003, 19: 207-235.
|
24 |
CHRISTOFORI G. Changing neighbours, changing behaviour: cell adhesion molecule-mediated signalling during tumour progression[J]. EMBO J, 2003, 22(10): 2318-2323.
|
25 |
LAMOUILLE S, XU J, DERYNCK R. Molecular mechanisms of epithelial-mesenchymal transition[J]. Nat Rev Mol Cell Biol, 2014, 15(3): 178-196.
|
26 |
XU Z L, CHEN Z M, PENG M S, et al. MicroRNA miR-490-5p suppresses pancreatic cancer through regulating epithelial-mesenchymal transition via targeting MAGI2 antisense RNA 3[J]. Bioengineered, 2022, 13(2): 2673-2685.
|
27 |
PIERCEALL W E, WOODARD A S, MORROW J S, et al. Frequent alterations in E-cadherin and α- and β-catenin expression in human breast cancer cell lines[J]. Oncogene, 1995, 11(7): 1319-1326.
|
28 |
DERYCKE L D M, BRACKE M E. N-cadherin in the spotlight of cell-cell adhesion, differentiation, embryogenesis, invasion and signalling[J]. Int J Dev Biol, 2004, 48(5/6): 463-476.
|
29 |
GRABOWSKA M M, DAY M L. Soluble E-cadherin: more than a symptom of disease[J]. Front Biosci (Landmark Ed), 2012, 17(5): 1948-1964.
|
30 |
KATZ J, YANG Q B, ZHANG P, et al. Hydrolysis of epithelial junctional proteins by Porphyromonas gingivalis gingipains[J]. Infect Immun, 2002, 70(5): 2512-2518.
|